Aztreonam pharmacokinetics in burn patients

Area of Science:

• Pharmacology
• Critical Care Medicine
• Burn Injury Management

Background:

• Severe burn injuries significantly impact drug pharmacokinetics.
• Understanding aztreonam behavior in burn patients is crucial for effective treatment.
• Previous studies have not fully elucidated aztreonam's pharmacokinetic profile in this population.

Purpose of the Study:

• To investigate the pharmacokinetics of aztreonam in adult patients with severe burn injuries.
• To determine the influence of burn severity on aztreonam's pharmacokinetic parameters.
• To assess the utility of creatinine clearance (CLCR) in predicting aztreonam clearance in burn patients.

Main Methods:

• Studied eight adult patients with severe burn injuries (average 49% TBSA).
• Measured aztreonam concentrations using high-performance liquid chromatography (HPLC).
• Applied a two-compartment model to analyze pharmacokinetic data, comparing first dose and steady-state parameters.

Main Results:

• Aztreonam volume of distribution was approximately 30% higher in burn patients compared to other populations.
• Total drug clearance and renal drug clearance correlated strongly with creatinine clearance (CLCR).
• Burn extent showed poor correlation with most parameters, except for volume of distribution at steady state.

Conclusions:

• Aztreonam pharmacokinetics are altered in patients with severe thermal injuries.
• Creatinine clearance (CLCR) serves as a reliable indicator for assessing aztreonam clearance in burn patients.
• These findings support individualized dosing strategies based on CLCR in burn care.